Archive - April 2022
COVID-19 Vaccine: How Common Are Heart Issues After Doses? New Studies Find Results
Magic Mushroom Psilocybin Study Found Long-Term Improvement In Depression
2-Dose Vaccines Provide Better Protection Against Hospitalization, Death In COVID-19 Survivors
FDA lifts hold on Gilead’s clinical trials for leukaemia
AbbVie’s Rinvoq accepted by SMC for atopic dermatitis
Pfizer appoints David Denton as chief financial officer and executive vice president
Engetix and Takeda announce expanded collaboration for anti-fibrotic therapies
Novacyt PCR COVID-19 test approved under CTDA legislation